In:
Immunotherapy, Future Medicine Ltd, Vol. 16, No. 1 ( 2024-01), p. 43-53
Kurzfassung:
Tweetable abstract Allergen immunotherapy using carbamylated monomeric allergoids is safe as the number of adverse reactions is negligible.
Materialart:
Online-Ressource
ISSN:
1750-743X
,
1750-7448
DOI:
10.2217/imt-2023-0126
Sprache:
Englisch
Verlag:
Future Medicine Ltd
Publikationsdatum:
2024